Kuo-Ting Lee, Dao-Peng Chen, Zhu-Jun Loh, Wei-Pang Chung, Chih-Yang Wang, Pai-Sheng Chen, Chun Hei Antonio Cheung, Chih-Peng Chang, Hui-Ping Hsu
{"title":"Benign polymorphisms in the BRCA genes with linkage disequilibrium is associated with cancer characteristics","authors":"Kuo-Ting Lee, Dao-Peng Chen, Zhu-Jun Loh, Wei-Pang Chung, Chih-Yang Wang, Pai-Sheng Chen, Chun Hei Antonio Cheung, Chih-Peng Chang, Hui-Ping Hsu","doi":"10.1111/cas.16364","DOIUrl":null,"url":null,"abstract":"<p>Germline pathogenic mutation of the <i>BRCA</i> gene increases the prevalence of breast cancer. Reports on the benign variants of <i>BRCA</i> genes are limited. However, the definition of these variants might be altered with the accumulation of clinical evidence. Therefore, in the present study, we focused on benign single nucleotide polymorphisms (SNPs) of <i>BRCA</i> genes. Linkage disequilibrium was calculated from whole genome sequencing of the <i>BRCA</i> genes obtained from 500 healthy controls and 49 breast cancer patients. Sanger sequencing was used to confirm the mutation. The linkage disequilibrium was noted for seven and three SNPs in the <i>BRCA1</i> and <i>BRCA2</i> genes, respectively. Breast cancer with <i>BRCA1</i>/<i>2</i> linkage disequilibrium was not correlated with a personal history of benign diseases or family history of cancer. Nevertheless, breast cancer with <i>BRCA1</i> linkage disequilibrium was correlated with high tumor-infiltrating lymphocytes and positive extensive intraductal components. The patients with <i>BRCA1</i> linkage disequilibrium tended to have worse disease-specific survival. Cancers with <i>BRCA2</i> linkage disequilibrium are associated with a lower ratio of grade III cancer. Moreover, patients with <i>BRCA2</i> linkage disequilibrium tended to have better overall survival. In conclusion, linkage disequilibrium from benign SNPs of the <i>BRCA</i> genes potentially affects cancer characteristics.</p>","PeriodicalId":9580,"journal":{"name":"Cancer Science","volume":"115 12","pages":"3973-3985"},"PeriodicalIF":4.5000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cas.16364","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cas.16364","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Germline pathogenic mutation of the BRCA gene increases the prevalence of breast cancer. Reports on the benign variants of BRCA genes are limited. However, the definition of these variants might be altered with the accumulation of clinical evidence. Therefore, in the present study, we focused on benign single nucleotide polymorphisms (SNPs) of BRCA genes. Linkage disequilibrium was calculated from whole genome sequencing of the BRCA genes obtained from 500 healthy controls and 49 breast cancer patients. Sanger sequencing was used to confirm the mutation. The linkage disequilibrium was noted for seven and three SNPs in the BRCA1 and BRCA2 genes, respectively. Breast cancer with BRCA1/2 linkage disequilibrium was not correlated with a personal history of benign diseases or family history of cancer. Nevertheless, breast cancer with BRCA1 linkage disequilibrium was correlated with high tumor-infiltrating lymphocytes and positive extensive intraductal components. The patients with BRCA1 linkage disequilibrium tended to have worse disease-specific survival. Cancers with BRCA2 linkage disequilibrium are associated with a lower ratio of grade III cancer. Moreover, patients with BRCA2 linkage disequilibrium tended to have better overall survival. In conclusion, linkage disequilibrium from benign SNPs of the BRCA genes potentially affects cancer characteristics.
期刊介绍:
Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.
Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.